J. John Goodman

510 total citations
8 papers, 351 citations indexed

About

J. John Goodman is a scholar working on Dermatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. John Goodman has authored 8 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Dermatology, 4 papers in Epidemiology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. John Goodman's work include Photodynamic Therapy Research Studies (2 papers), Herpesvirus Infections and Treatments (2 papers) and Cancer and Skin Lesions (2 papers). J. John Goodman is often cited by papers focused on Photodynamic Therapy Research Studies (2 papers), Herpesvirus Infections and Treatments (2 papers) and Cancer and Skin Lesions (2 papers). J. John Goodman collaborates with scholars based in United States, Canada and Switzerland. J. John Goodman's co-authors include Gerald D. Weinstein, Edward W. B. Jeffes, Tena M. Rallis, Scott D. Glazer, Daniel Piacquadio, Charles R. Taylor, Mark Ling, Joseph F. Fowler, Luciann L. Hruza and Richard K. Scher and has published in prestigious journals such as British Journal of Dermatology, Clinical Therapeutics and Contact Dermatitis.

In The Last Decade

J. John Goodman

7 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. John Goodman United States 7 188 179 115 72 47 8 351
Jo‐Ann See Australia 11 364 1.9× 220 1.2× 178 1.5× 60 0.8× 60 1.3× 19 496
Rossana Capezzera Italy 11 244 1.3× 205 1.1× 177 1.5× 47 0.7× 36 0.8× 13 423
Tena M. Rallis United States 7 249 1.3× 172 1.0× 114 1.0× 9 0.1× 43 0.9× 11 351
Nancy G. Silvis United States 8 181 1.0× 135 0.8× 42 0.4× 27 0.4× 137 2.9× 12 348
H Fogh Denmark 9 245 1.3× 282 1.6× 122 1.1× 49 0.7× 60 1.3× 17 516
Michael K. McCray United States 5 234 1.2× 320 1.8× 115 1.0× 14 0.2× 139 3.0× 7 411
Valerie R. Yanofsky United States 7 130 0.7× 232 1.3× 25 0.2× 105 1.5× 126 2.7× 10 428
José María Ortiz Salvador Spain 11 182 1.0× 81 0.5× 21 0.2× 82 1.1× 20 0.4× 48 333
Paola Pasquali Spain 11 125 0.7× 132 0.7× 22 0.2× 34 0.5× 180 3.8× 41 345
A. Aliaga Spain 13 204 1.1× 99 0.6× 21 0.2× 55 0.8× 78 1.7× 28 389

Countries citing papers authored by J. John Goodman

Since Specialization
Citations

This map shows the geographic impact of J. John Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. John Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. John Goodman more than expected).

Fields of papers citing papers by J. John Goodman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. John Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. John Goodman. The network helps show where J. John Goodman may publish in the future.

Co-authorship network of co-authors of J. John Goodman

This figure shows the co-authorship network connecting the top 25 collaborators of J. John Goodman. A scholar is included among the top collaborators of J. John Goodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. John Goodman. J. John Goodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Thaçi, Diamant, et al.. (2015). Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE). British Journal of Dermatology. 173(3). 777–787. 68 indexed citations
2.
Krueger, Gerald G., Lawrence F. Eichenfield, J. John Goodman, et al.. (2007). Pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and pediatric patients with moderate to severe atopic dermatitis.. PubMed. 6(2). 185–93. 23 indexed citations
3.
Kaul, Nalini, et al.. (2007). North American Efficacy and Safety of a Novel Pediculicide Rinse, Isopropyl Myristate 50% (Resultz). Journal of Cutaneous Medicine and Surgery. 11(5). 161–167. 22 indexed citations
4.
Piacquadio, Daniel, Joseph F. Fowler, Scott D. Glazer, et al.. (2004). Photodynamic Therapy With Aminolevulinic Acid Topical Solution andVisible Blue Light in the Treatment of Multiple Actinic Keratoses of the Faceand Scalp. Archives of Dermatology. 140(1). 41–6. 172 indexed citations
5.
Piacquadio, Daniel, Joseph F. Fowler, Scott D. Glazer, et al.. (2004). Photodynamic Therapy With Aminolevulinic Acid Topical Solution and Visible Blue Light in the Treatment of Multiple Actinic Keratoses of the Face and Scalp. 16 indexed citations
6.
Boon, Ron, et al.. (2000). Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: A randomized, double-blind, placebo-controlled trial. Clinical Therapeutics. 22(1). 76–90. 37 indexed citations
7.
Goodman, J. John. (1995). Modern Chinese acupuncture. Complementary Therapies in Medicine. 3(1). 60–60. 1 indexed citations
8.
Schwartz, S. R., et al.. (1987). Human safety study of body lotion containing Kathon® CG. Contact Dermatitis. 16(4). 203–207. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026